Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Hemosol, Inc. (NasdaqNM:HMSL)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research
Recent Events
Aug 31Price hit new 52-week low ($3.43)
Location
2 Meridian Road
Toronto, M9W 4Z7, Canada
Phone: (416) 798-0700
Fax: (416) 798-0152
Email: hml@hemosol.com
Employees (last reported count): 140
Financial Links
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Free Annual Report
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 16%
·Institutional: 15% (18% of float)
(29 institutions)
·Net Inst. Buying: 1.71M shares (+25.57%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Hemosol, Inc. is an integrated biopharmaceutical company developing a multi-product pipeline for global markets based on proprietary technologies for use initially in the treatment of hemoglobin deficiencies. Hemosol has a broad range of products in development which include: hemoglobin based oxygen carriers (HBOCs) including Hemolink; hemoglobin therapeutics to treat a variety of diseases such as reperfusion injury, hepatitis C and cancers of the liver; and cell therapy for the treatment of cancer and infectious disease. The Company also is developing methods to harvest hemoglobin, from cells grown and expanded under controlled manufacturing conditions outside of the human body.
More from Market Guide: Expanded Business Description

Financial Summary
Hemosol, Inc. is an integrated biopharmaceutical company developing a multi-product pipeline for global markets based on propietary technologies, used initially in the treatment of hemoglobin deficiencies. For the three months ended 3/30/01, the Company reported no revenues. Net loss rose 22% to C$6.9 million. Higher loss reflects higher clinical, regulatory, scientific and process R&D expenditures and higher administration, marketing and business development expenses.

Recent Earnings Announcement
For the 3 months ended 06/30/2001, after tax earnings were -14,042. (Preliminary; reported in thousands of Canadian Dollars.)

More from Market Guide: Significant Developments

Officers

Position
Edward RygielChairman
John KennedyPres, CEO, Director
Lee HartwellCFO, VP, Corp. Devel.
Dirk Alkema, Ph.D.VP-Operations and Regulatory Affairs
Lee MalcolmVP of Marketing
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:HMSLAs of 31-Aug-2001
Price and Volume
52-Week Low
on 31-Aug-2001
$3.43 
Recent Price$3.44 
52-Week High
on 22-May-2001
$10.84 
Daily Volume (3-month avg)70.8K
Daily Volume (10-day avg)47.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y]
13-Week Change-64.5%
13-Week Change
relative to S&P500
-60.5%
Share-Related Items
Market Capitalization$111.0M
Shares Outstanding32.3M
Float27.1M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq*)$2.97 
Earnings (ttm)-$0.67 
Earnings (mrq)-$0.23 
SalesN/A 
Cash (mrq*)$2.41 
Valuation Ratios
Price/Book (mrq*)1.16 
Price/EarningsN/A 
Price/SalesN/A 
Income Statements
SalesN/A 
EBITDA (ttm*)-$21.1M
Income available to common (ttm)-$23.8M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter
(fully updated)
30-Mar-2001
Most recent quarter
(flash earnings)
30-June-2001
Management Effectiveness
Return on Assets (ttm)-38.51%
Return on Equity (ttm)-40.57%
Financial Strength
Current Ratio (mrq*)16.64 
Debt/Equity (mrq*)0 
Total Cash (mrq)$106.7M
Short Interest
As of 8-Aug-2001
Shares Short791.0K
Percent of Float2.9%
Shares Short
(Prior Month)
0 
Short Ratio4.82 
Daily Volume164.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001, except mrq*/ttm* items as of 30-Mar-2001);   dollar amounts based on an exchange rate of 1.55 Canadian Dollars/US Dollar

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.